|
Cardiovascular Pharmacology
Citations 111-120 of 640 total displayed.
|
Past content
(since Jan 1999):
|
- Letters to the Editor
It Is the Plasma Renin Activity Level That Counts, not Stoichiometry
- Jean E. Sealey and John H. Laragh
Hypertension published July 7, 2008, doi:10.1161/HYPERTENSIONAHA.108.116319
[Abstract]
- Scientific Contributions
Cerebral Hemodynamics During Treatment With Sodium Nitroprusside Versus Labetalol in Malignant Hypertension
- Rogier V. Immink, Bert-Jan H. van den Born, Gert A. van Montfrans, Yu-Sok Kim, Markus W. Hollmann, and Johannes J. van Lieshout
Hypertension published July 7, 2008, doi:10.1161/HYPERTENSIONAHA.108.110395
[Abstract]
- Scientific Contributions
Deletion of Transient Receptor Potential Vanilloid Type 1 Receptors Exaggerates Renal Damage in Deoxycorticosterone Acetate-Salt Hypertension
- Youping Wang, Dagmar Babánková, Jie Huang, Greg M. Swain, and Donna H. Wang
Hypertension published July 7, 2008, doi:10.1161/HYPERTENSIONAHA.108.110197
[Abstract]
- Brief Reviews
Thiazide-Induced Dysglycemia: Call for Research From a Working Group From the National Heart, Lung, and Blood Institute
- Barry L. Carter, Paula T. Einhorn, Michael Brands, Jiang He, Jeffrey A. Cutler, Paul K. Whelton, George L. Bakris, Frederick L. Brancati, William C. Cushman, Suzanne Oparil, and Jackson T. Wright, Jr
Hypertension 2008;52:30-36; published online before print as doi:10.1161/HYPERTENSIONAHA.108.114389
[Full text]
- Editorial Commentaries
Treatment-Sensitive Premature Renal and Heart Senescence in Hypertension
- Martin W. Bergmann, Laura Zelarayan, and Christina Gehrke
Hypertension 2008;52:61-62; published online before print as doi:10.1161/HYPERTENSIONAHA.107.108563
[Full text]
- Original Articles
Hypertension Induces Somatic Cellular Senescence in Rats and Humans by Induction of Cell Cycle Inhibitor p16INK4a
- Jens H. Westhoff, Karl F. Hilgers, Mario P. Steinbach, Andrea Hartner, Bernd Klanke, Kerstin Amann, and Anette Melk
Hypertension 2008;52:123-129; published online before print as doi:10.1161/HYPERTENSIONAHA.107.099432
[Abstract]
[Full text]
- Editorial Commentary
Antihypertensive Therapy in Children. Implications for Future Studies
- Alan R. Sinaiko
Hypertension published June 30, 2008, doi:10.1161/HYPERTENSIONAHA.108.112433
[Abstract]
- Scientific Contributions
Efficacy and Safety of the Angiotensin Receptor Blocker Valsartan in Children With Hypertension Aged 1 to 5 Years
- Joseph T. Flynn, Kevin E.C. Meyers, Jose Pacheco Neto, Rejane de Paula Meneses, Aleksandra Zurowska, Arvind Bagga, Lionel Mattheyse, Victor Shi, Jitendra Gupte, Susan Solar-Yohay, Guangyang Han for the Pediatric Valsartan Study Group
Hypertension published June 30, 2008, doi:10.1161/HYPERTENSIONAHA.108.111054
[Abstract]
- Scientific Contributions
Serotonin 5-HT2B Receptor Blockade Prevents Reactive Oxygen Species–Induced Cardiac Hypertrophy in Mice
- Laurent Monassier, Marc-André Laplante, Fabrice Jaffré, Pascal Bousquet, Luc Maroteaux, and Jacques de Champlain
Hypertension published June 30, 2008, doi:10.1161/HYPERTENSIONAHA.107.105551
[Abstract]
- Scientific Contributions
History of Hypertension and Eplerenone in Patients With Acute Myocardial Infarction Complicated by Heart Failure
- Bertram Pitt, Ali Ahmed, Thomas E. Love, Henry Krum, Jose Nicolau, José S. Cardoso, Alexander Parkhomenko, Michael Aschermann, Ramon Corbalán, Henry Solomon, Harry Shi, and Faiez Zannad
Hypertension published June 16, 2008, doi:10.1161/HYPERTENSIONAHA.107.109314
[Abstract]
|
|
